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ABSTRACT
Objective: To examine the prevalence of atrial
fibrillation (AF) and cardiac structural characteristics in
Indigenous and non-Indigenous Australians.
Design: Retrospective cross-sectional study linking
clinical, echocardiography and administrative databases
over a 10-year period.
Setting: A tertiary, university teaching hospital in
Adelaide, Australia.
Participants: Indigenous and non-Indigenous
Australians.
Main outcome measures: AF prevalence and
echocardiographic characteristics.
Results: Indigenous Australians with AF were
significantly younger compared to non-Indigenous
Australians (55±13 vs 75±13 years, p<0.001). As a
result, racial differences in AF prevalence and left atrial
diameter varied according to age. In those under
60 years of age, Indigenous Australians had a
significantly greater AF prevalence (2.57 vs1.73%,
p<0.001) and left atrial diameters (39±7 vs 37±7 mm,
p<0.001) compared to non-Indigenous Australians. In
those aged 60 years and above, however, non-
Indigenous Australians had significantly greater AF
prevalence (9.26 vs 4.61%, p<0.001) and left atrial
diameters (39±7 vs 37±7 mm, p<0.001). Left
ventricular ejection fractions were less in Indigenous
Australians under 60 years of age (49±14 vs 55±11%,
p<0.001) and not statistically different in those aged
60 years and above (47±11 vs 52±13, p=0.074)
compared to non-Indigenous Australians. Despite their
younger age, Indigenous Australians with AF had
similar or greater rates of cardiovascular comorbidities
than non-Indigenous Australians with AF.
Conclusions: Young Indigenous Australians have a
significantly greater prevalence of AF than their non-
Indigenous counterparts. In contrast, older non-
Indigenous Australians have a greater prevalence of AF
compared to their Indigenous counterparts. These
observations may be mediated by age-based
differences in comorbid cardiovascular conditions, left
atrial diameter and left ventricular ejection fraction. Our
findings suggest that AF is likely to be contributing to
the greater burden of morbidity and mortality
experienced by young Indigenous Australians. Further
study is required to elucidate whether strategies to
prevent and better manage AF in Indigenous
Australians may reduce this burden.
INTRODUCTION
Atrial ﬁbrillation (AF) is the most common
clinical arrhythmia and has a rising preva-
lence.1–7 As a result, recent data suggest that
the burden of AF may already exceed that of
other common cardiovascular conditions.6
Despite the frequency of cardiovascular
disease in Indigenous Australians, AF is a con-
dition that remains to be characterised in this
population. Given the emerging evidence
from other countries suggesting that AF may
vary according to race,2 8–12 we sought to
characterise the prevalence of AF in
Indigenous and non-Indigenous Australians.
Given the strong relationship between cardiac
structure and AF, in particular left atrial diam-
eter, we also examined for racial differences
in echocardiographic characteristics.
Strengths and limitations of this study
▪ This study describes the prevalence of atrial fib-
rillation (AF) in Indigenous Australians which has
not been previously characterised.
▪ We found that young Indigenous Australians have
a significantly greater prevalence of AF compared
to their non-Indigenous counterparts. In contrast,
AF was more prevalent in elderly non-Indigenous
Australians compared to Indigenous Australians.
▪ Age-based differences in comorbid cardiovascu-
lar conditions, left atrial dilatation and left ven-
tricular dysfunction may in-part explain our
observations.
▪ Limitations of this study include the potential for
asymptomatic AF to not be detected, potential
incomplete identification of Indigenous Australian
race and the mainly hospital and urban-based
participants.
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METHODS
Study population
The Royal Adelaide Hospital is a large tertiary referral
centre and teaching hospital of the Universities of
Adelaide and South Australia. We identiﬁed all
Indigenous and non-Indigenous individuals admitted
over a 10-year period from 2000 through 2009 inclusive
from the coding database.
Data collection
The International Classiﬁcation of Diseases, 10th Rev,
Australian Modiﬁcation (ICD-10-AM) was used for coding
hospital diagnoses. AF was deﬁned for patients with
ICD-10-AM diagnosis code I48 that include AF and atrial
ﬂutter. Hypertension was deﬁned for patients with
ICD-10-AM diagnosis codes I10-I15. Ischaemic heart
disease was deﬁned for patients with ICD-10-AM diagno-
sis codes I20-I25. Heart failure was deﬁned for patients
with ICD-10-AM diagnosis code I50. Conditions were
deemed to be present if they were coded as being either
a principal or secondary diagnosis during any hospital-
isation. In addition, it was noted whether these condi-
tions were pre-existing at ﬁrst clinical contact, or
whether they were new diagnoses performed during
study period at subsequent hospitalisations.
Echocardiographic study
A subset of individuals underwent resting transthoracic
two-dimensional guided M-mode Doppler echocardio-
grams undertaken with standard techniques in the left
lateral decubitus position. Patients with AF were excluded
from this analysis. Standard M-mode left atrial linear
dimensions were obtained from the parasternal long-axis
view in end systole.13 Measurements of left ventricular end-
diastolic diameter, left ventricular end-systolic diameter
and left ventricular ejection fraction were additionally
determined in accordance with the American Society of
Echocardiography guidelines.13 Left ventricular ejection
fraction was calculated using Biplane Simpson’s rule.
Statistical analysis
Continuous variables are reported as mean±SD as appro-
priate. Study sample characteristics were compared
using an independent samples t test or χ2 test as appro-
priate. Binary logistic regression analyses were employed
to determine associations with prevalent AF. Binary
linear regression analyses were employed to determine
associations with echocardiographic characteristics.
Statistical tests were performed using SAS V.9.2 (SAS




A total of 629 024 hospitalisations for 204 668 individuals
were identiﬁed (table 1). Of these, 22 821 (3.6%) and
606 203 (96.4%) hospitalisations were for Indigenous and
non-Indigenous Australians, respectively. Compared to
non-Indigenous Australians, Indigenous Australians were
more likely to be younger and woman. While pre-existing
hypertension, new hypertension, new ischaemic heart
disease and new congestive heart failure were more preva-
lent in non-Indigenous Australians, pre-existing ischaemic
heart disease was more prevalent in Indigenous
Australians. There were no signiﬁcant racial differences in
the prevalence of pre-existing congestive heart failure.
Race and AF
A total of 14373 individuals had a diagnosis of AF..
Overall, Indigenous Australian AF patients were younger
than non-Indigenous Australian AF patients (55±13 vs 75
±13, p<0.0001). As a result, the prevalence of AF in
Indigenous and non-Indigenous Australians differed
according to age. In those under 60 years of age, the
prevalence of AF was greater in Indigenous Australians
(2.57 vs 1.73%, p<0.0001; see ﬁgure 1). In contrast, in
those aged 60 years and above, the prevalence of AF was
greater in non-Indigenous Australians (9.26 vs 4.61%,
p<0.0001).
















(n=14 152) p Value
Age, year (SD) 42.2 (16.2) 54.0 (20.9) <0.001 55.4 (13.2) 74.5 (13.1) <0.001
Male, % (n) 51.7 (3049) 53.8 (106 992) 0.002 52.5 (116) 54.1 (7662) 0.63
Pre-existing hypertension, % (n) 15.0 (886) 47.9 (24 478) <0.001 32.6 (72) 32.1 (4539) 0.87
New hypertension, % (n) 4.3 (252) 19.8 (10 103) <0.001 16.3 (36) 16.5 (2329) 0.95
Pre-existing ischaemic heart disease,
% (n)
13.3 (783) 9.6 (19 071) <0.001 36.2 (80) 26.3 (3715) <0.001
New ischaemic heart disease, % (n) 2.6 (153) 3.1 (6096) 0.04 13.1 (29) 12.6 (1777) 0.80
Pre-existing congestive heart failure, % (n) 3.3 (193) 3.3 (6504) 0.99 17.2 (38) 17.7 (2504) 0.85
New congestive heart failure, % (n) 1.7 (101) 2.5 (4936) <0.001 16.7 (37) 15.2 (2149) 0.52
AF, atrial fibrillation; n, number; SD, standard deviation.
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Despite their younger age, Indigenous Australian AF
patients had a similar or greater prevalence of cardiovas-
cular comorbidities than their non-Indigenous counter-
parts (table 1). As a result, controlling for these
comorbidities in multivariable analyses attenuated the
relationship between Indigenous Australian status and
prevalent AF (table 2).
Echocardiography characteristics
A total of 4477 echocardiograms were analysed. The
mean left atrial diameter was 38±7 mm and mean left
ventricular ejection fraction 53±12%. Echocardiographic
characteristics also exhibited racial variation according
to age. In those under 60 years of age, Indigenous
Australians had a greater mean left atrial diameter (39
±7 vs 37±7 mm, p<0.001). In those aged 60 years and
above, non-Indigenous Australians had a greater mean
left atrial diameter (39±7 vs 37±7 mm, p<0.001). Left
ventricular ejection fractions were lesser in Indigenous
Australians under 60 years of age (49±14 vs 55±11%,
p<0.001) though not in those aged 60 years and above
(47±11 vs 52±13, p=0.074). In multivariable-adjusted
regression models, Indigenous Australian status
remained signiﬁcantly associated with greater left atrial
diameter and lower left ventricular ejection fraction
(tables 3 and 4).
DISCUSSION
Major findings
This report provides the ﬁrst comparative assessment of
AF in Indigenous and non-Indigenous Australians. We
found that AF was more prevalent among Indigenous
Australians under 60 years of age and more prevalent in
non-Indigenous Australians aged 60 years and above.
Indigenous Australians under 60 years of age, but not
those aged 60 years and above, had signiﬁcantly greater
left atrial diameters and rates of left ventricular systolic
dysfunction than non-Indigenous counterparts after
multivariable adjustment. These differences in cardiac
structure and function may in-part explain the excess
prevalence of AF seen in young Indigenous Australians
that would contribute to the disparity in life-
expectancies between Indigenous and non-Indigenous
Australians.
Evidence for racial variation in the prevalence of AF
A number of previous studies have reported that
Caucasian race is associated with a greater prevalence of
AF and that African American race is associated with a
lower prevalence of AF.2 8–12 Since then, further differ-
ences in the prevalence of AF have been variably noted
in Chinese, Japanese, Korean, African and Latino popu-
lations.12 14–20 Despite the above studies, however, there
continues to be a paucity of epidemiological data on AF
from many parts of the world, including Australasia.
In the present study, we thus sought to characterise AF
in hospitalised Indigenous Australians. Compared to
their non-Indigenous counterparts, we found a greater
prevalence of AF in young Indigenous Australians, and
in contrast, a lesser prevalence of AF in older
Indigenous Australians.
Possible mechanisms underlying racial differences in AF
prevalence
Despite the expanding literature describing racial differ-
ences in AF prevalence, the mechanisms underlying
these observations remain unclear. There is a growing
body of evidence suggesting that there exists a genetic
predisposition to AF.21 Since familial AF was ﬁrst
reported in 1942, recent studies have shown an
increased risk of AF associated with family history,
various mutations and genetic loci.22 One study
Figure 1 Graph showing the race-specific prevalence of
atrial fibrillation in Indigenous and non-Indigenous Australians
according to age group.
Table 2 Multivariable-adjusted associations with prevalent atrial fibrillation
Univariate OR (CI) p Value Multivariate OR (CI) p Value
Indigenous Australian 1.471 (1.233 to 1.755) <0.001 1.183 (0.977 to 1.432) 0.085
Age 1.086 (1.082 to 1.091) <0.001 1.069 (1.064 to 1.074) <0.001
Male 1.992 (1.817 to 2.185) <0.001 1.798 (1.633 to 1.979) <0.001
Hypertension 6.138 (5.603 to 6.723) <0.001 2.109 (1.892 to 2.352) <0.001
Ischaemic heart disease 6.341 (5.761 to 6.979) <0.001 1.556 (1.383 to 1.750) <0.001
Congestive heart failure 21.562 (19.146 to 24.283) <0.001 8.812 (7.72 to 10.059) <0.001
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described how European ancestry was a risk factor for
developing AF, however, we are not aware of any compar-
able reports including Indigenous Australians.23 It has
also been hypothesised that genes governing atrial
dimensions may be responsible. Left atrial diameter is a
well-established risk factor for AF.9 Two previous studies
have noted smaller left atria in African Americans com-
pared to Caucasians, which they hypothesised might
contribute to their lower burden of AF.12 24 Our ﬁnding
that Indigenous Australians have larger left atria may
thus in-part explain the excess burden of AF seen in
younger Indigenous Australians observed in the present
study. Similarly, left ventricular systolic dysfunction is a
powerful risk factor for AF and our data conﬁrm the
previously described excess burden of ventricular dys-
function in Indigenous Australians.25
Varying risk factor proﬁles have also been previously
speculated to be in-part responsible for racial differences
in AF. Indigenous Australians have an excess burden of
cardiovascular disease and a 11-year lower life expect-
ancy compared to other Australians, reﬂecting
entrenched social, economic and educational disadvan-
tage.26 27 In recent data from the Heart of the Heart
Study, comprehensive heart failure and risk factors data
in Indigenous Australians was reported.25 In six
Indigenous Australian communities in Central Australia,
the burden of heart failure and risk factors was
extremely high. Consistent with these ﬁndings, in our
hospitalised and comparatively urban population of
Indigenous Australians with AF, we also noted similar or
greater rates of cardiovascular comorbidities compared
to non-Indigenous Australians, despite their younger
age. However, varying risk factor proﬁles are not always
consistent with racial differences in AF prevalence; in
African-American populations, for example, there is a
paradoxically lower prevalence of AF in spite of their
greater risk factor burden.28 29
It has also been hypothesised that under ascertain-
ment of AF could explain some divergences, with a
reported lower burden of AF in African-Americans
potentially a result of poorer access to medical care.
However, under ascertainment would be less likely in
prior reports from integrated healthcare facilities and
prospective studies where the ability to diagnose AF has
been consistent across races.2 12 Additionally, this would
not readily explain the greater, and not lesser, burden of
AF noted in younger Indigenous Australians observed in
the present study.
Differences in mortality might in-part explain the
greater AF prevalence seen in older non-Indigenous
Australians. The disproportionately early morbidity and
mortality faced by Indigenous Australians could in turn
lead to a lower prevalence of AF in older age groups if
only healthier individuals survived; simultaneously,
access to better medical care in non-Indigenous
Australians would improve survival despite concurrent
comorbidities such as AF. Such a possible mortality dif-
ference may have resulted in the similar overall preva-
lence of AF observed after multivariable adjustment,
despite the greater prevalence of AF in younger
Indigenous Australians.
Implications
From a mechanistic perspective, our ﬁndings further
support the notion that differences in cardiac structure
and function may underlie racial variation in AF preva-
lence. On a clinical level, the excess burden of AF and
other comorbidities observed in young Indigenous
Table 3 Multivariable-adjusted associations with left atrial diameter
Univariate regressions (CI) p Value Multivariate regressions (CI) p Value
Indigenous Australian 0.255 (0.143 to 0.367) <0.001 0.261 (0.096 to 0.426) 0.002
Age 0.016 (0.013 to 0.018) <0.001 0.012 (0.008 to 0.016) <0.001
Male 0.299 (0.234 to 0.365) <0.001 0.344 (0.249 to 0.439) <0.001
Hypertension 0.249 (0.169 to 0.329) <0.001 0.135 (0.011 to 0.259) <0.001
Ischaemic heart disease 0.301 (0.224 to 0.379) <0.001 0.043 (−0.071 to 0.156) 0.46
Congestive heart failure 0.653 (0.530 to 0.775) <0.001 0.417 (0.232 to 0.602) <0.001
LV ejection fraction −0.022 (−0.026 to −0.018) <0.001 −0.012 (−0.017 to −0.008) <0.001
LV, left ventricular.
Table 4 Multivariable-adjusted associations with left ventricular ejection fraction
Univariate p Value Multivariate p Value
Indigenous Australian −5.915 (−8.908 to −2.923) <0.001 −5.050 (−7.621 to −2.479) <0.001
Age −0.101 (−0.164 to −0.038) 0.002 −0.049 (−0.105 to 0.008) 0.09
Male −2.166 (−3.940 to −0.039) 0.017 −2.525 (−4.015 to −1.035) 0.001
Hypertension −3.266 (−5.436 to −1.096) 0.003 −0.675 (−2.626 to 1.276) 0.497
Ischaemic heart disease −5.575 (−7.500 to −3.651) <0.001 −3.324 (−5.098 to −1.550) <0.001
Congestive heart failure −21.225 (−23.735 to −18.715) <0.001 −20.632 (−23.120 to −18.144) <0.001
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Australians is of concern. These data suggest that risk
factor modiﬁcation may mitigate the excess burden of
morbidity and mortality due to AF in younger
Indigenous Australians.
Study limitations
Our study has a number of limitations which limit the
genereralisability of our results. First, asymptomatic AF
may not have been detected. Second, there may be
incomplete identiﬁcation of Indigenous Australians in
hospital records given race was self-reported and the
racial make-up of any given individual can be complex;
however, we demonstrated a difference in AF prevalence
in spite of this. Third, a signiﬁcant number of
Indigenous Australians reside in rural regions, compared
to the presently studied urban setting. Fourth, our
cohort comprised hospitalised patients who, in contrast
to the general population, have a greater prevalence of
comorbidities and thus AF. As a result, our ﬁndings may
not necessarily reﬂect that of the general population.
Finally, there may be other potential confounders that
were not measured, including differences in lifestyle
factors and other predictors of AF such as diabetes,
obesity and obstructive sleep apnoea.30
CONCLUSION
To the best of our knowledge, the present study provides
the ﬁrst assessment of AF in Indigenous Australians.
Young, hospitalised Indigenous Australians have a signiﬁ-
cantly greater prevalence of AF than their
non-Indigenous counterparts. These ﬁndings may be due
in-part to more frequent comorbidities, larger left atrial
dimensions and greater rates of left ventricular systolic
dysfunction observed in young Indigenous Australians.
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